The author of 《Preparation of functionalized magnetic nanoparticles conjugated with feroxamine and their evaluation for pathogen detection》 were Martinez-Matamoros, Diana; Castro-Garcia, Socorro; Balado, Miguel; Matamoros-Veloza, Adriana; Camargo-Valero, Miller Alonso; Cespedes, Oscar; Rodriguez, Jaime; Lemos, Manuel L.; Jimenez, Carlos. And the article was published in RSC Advances in 2019. HPLC of Formula: 56602-33-6 The author mentioned the following in the article:
This work reports the preparation of a conjugate between amino-functionalized silica magnetite and the siderophore feroxamine. The morphol. and properties of the conjugate and intermediate magnetic nanoparticles (MNPs) were examined by powder X-ray diffraction (XRD), Fourier Transform IR spectroscopy (FT-IR), Raman spectroscopy, XPS, magnetization studies, zeta potential measurements, Transmission Electron Microscopy (TEM) and Energy Dispersive X-ray (EDX) mapping. Furthermore, this study investigated the interaction between the functionalized magnetic NPs and Yersinia enterocolitica wild type (WC-A) using SEM (SEM) and TEM images. In addition, the interaction between MNPs and a Y. enterocolitica mutant strain lacking feroxamine receptor FoxA, was also used to study the binding specificity. The results showed that the capture and isolation of Y. enterocolitica by the MNPs took place in all cases. Moreover, the specific interaction between the MNP conjugate and bacteria did not increase after blocking the free amine groups with t-butoxycarbonyl (Boc) and carboxylic acid (COOH) functional groups. Electrostatic surface interactions instead of mol. recognition between MNP conjugate and feroxamine receptor seem to rule the attachment of bacteria to the conjugate. After reading the article, we found that the author used ((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tris(dimethylamino)phosphonium hexafluorophosphate(V)(cas: 56602-33-6HPLC of Formula: 56602-33-6)
((1H-Benzo[d][1,2,3]triazol-1-yl)oxy)tris(dimethylamino)phosphonium hexafluorophosphate(V)(cas: 56602-33-6) is used as a reagent for peptide coupling, lactonization, selective esterification, amidation of alfa amino acids without racemization and synthesis of magnolamide for antioxidative activity and catalyst for 9-acridinecaroboxamide derivative. It acts as a substitute for (Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) reagent.HPLC of Formula: 56602-33-6
Referemce:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics